Morgan Stanley Celcuity Inc. Transaction History
Morgan Stanley
- $1.39 Trillion
- Q4 2024
A detailed history of Morgan Stanley transactions in Celcuity Inc. stock. As of the latest transaction made, Morgan Stanley holds 876,891 shares of CELC stock, worth $9.76 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
876,891
Previous 1,392,705
37.04%
Holding current value
$9.76 Million
Previous $20.8 Million
44.72%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding CELC
# of Institutions
103Shares Held
29.9MCall Options Held
17.5KPut Options Held
100-
Bvf Inc San Francisco, CA3.47MShares$38.6 Million1.7% of portfolio
-
Baker Bros. Advisors LP New York, NY2.68MShares$29.8 Million0.39% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.57MShares$28.5 Million2.34% of portfolio
-
Perceptive Advisors LLC New York, NY2.36MShares$26.3 Million1.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.65MShares$18.4 Million0.0% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $166M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...